Vés al contingut

A Multicentre, Randomised, Double-Blind, ParallelGroup, Active-Controlled, Phase 3b Study to Evaluate the Efficacy and Safety ofBenralizumab 30 mg SC in Eosinophilic Asthma Patients Uncontrolled on Medium-Dose Inhaled Corticosteroid Plus Long-acting ß2-Agonist

Obert
  • Codi protocol: D3250C00101
  • Codi EudraCT: No aplica
  • Grup de recerca: Pneumologia
  • Servei: Pneumologia
  • Investigador/a principal:  Muñoz Gall, Fco. Javier
  • Malaltia: Malalties del sistema respiratori
  • Fase: Fase III